M Elmi1,2, H Hussein3,4,5, S Nofech-Mozes1, B Curpen3,4, A Leahey1, N Look Hong1,2. 1. Division of General Surgery, Sunnybrook Health Sciences Centre-Odette Cancer Centre. 2. Department of Surgery, University of Toronto. 3. Division of Breast Imaging, Sunnybrook Health Sciences Centre; and. 4. Department of Medical Imaging, University of Toronto, Toronto, ON; and. 5. Department of Medical Imaging, Cairo University, Cairo, Egypt.
Abstract
BACKGROUND: The Odette Cancer Centre's recent implementation of a rapid diagnostic unit (rdu) for breast lesions has significantly decreased wait times to diagnosis. However, the economic impact of the unit remains unknown. This project defined the development and implementation costs and the operational costs of a breast rdu in a tertiary care facility. METHODS: From an institutional perspective, a budget impact analysis identified the direct costs associated with the breast rdu. A base-case model was also used to calculate the cost per patient to achieve a diagnosis. Sensitivity analyses computed costs based on variations in key components. Costs are adjusted to 2015 valuations using health care-specific consumer price indices and are reported in Canadian dollars. RESULTS: Initiation cost for the rdu was $366,243. The annual operational cost for support staff was $111,803. The average per-patient clinical cost for achieving a diagnosis was $770. Sensitivity analyses revealed that, if running at maximal institutional capacity, the total annual clinical cost for achieving a diagnosis could range between $136,080 and $702,675. CONCLUSIONS: Establishment and maintenance of a breast rdu requires significant investment to achieve reductions in time to diagnosis. Expenditures ought to be interpreted in the context of institutional patient volumes and trade-offs in patient-centred outcomes, including lessened patient anxiety and possibly shorter times to definitive treatment. Our study can be used as a resource-planning tool for future rdus in health care systems wishing to improve diagnostic efficiency.
BACKGROUND: The Odette Cancer Centre's recent implementation of a rapid diagnostic unit (rdu) for breast lesions has significantly decreased wait times to diagnosis. However, the economic impact of the unit remains unknown. This project defined the development and implementation costs and the operational costs of a breast rdu in a tertiary care facility. METHODS: From an institutional perspective, a budget impact analysis identified the direct costs associated with the breast rdu. A base-case model was also used to calculate the cost per patient to achieve a diagnosis. Sensitivity analyses computed costs based on variations in key components. Costs are adjusted to 2015 valuations using health care-specific consumer price indices and are reported in Canadian dollars. RESULTS: Initiation cost for the rdu was $366,243. The annual operational cost for support staff was $111,803. The average per-patient clinical cost for achieving a diagnosis was $770. Sensitivity analyses revealed that, if running at maximal institutional capacity, the total annual clinical cost for achieving a diagnosis could range between $136,080 and $702,675. CONCLUSIONS: Establishment and maintenance of a breast rdu requires significant investment to achieve reductions in time to diagnosis. Expenditures ought to be interpreted in the context of institutional patient volumes and trade-offs in patient-centred outcomes, including lessened patientanxiety and possibly shorter times to definitive treatment. Our study can be used as a resource-planning tool for future rdus in health care systems wishing to improve diagnostic efficiency.
Authors: Patrick L Fitzgibbons; Douglas A Murphy; M Elizabeth H Hammond; D Craig Allred; Paul N Valenstein Journal: Arch Pathol Lab Med Date: 2010-06 Impact factor: 5.534
Authors: Sean D Sullivan; Josephine A Mauskopf; Federico Augustovski; J Jaime Caro; Karen M Lee; Mark Minchin; Ewa Orlewska; Pete Penna; Jose-Manuel Rodriguez Barrios; Wen-Yi Shau Journal: Value Health Date: 2013-12-13 Impact factor: 5.725
Authors: Heather J Hoffman; Nancy L LaVerda; Heather A Young; Paul H Levine; Lisa M Alexander; Rachel Brem; Larisa Caicedo; Jennifer Eng-Wong; Wayne Frederick; William Funderburk; Elmer Huerta; Sandra Swain; Steven R Patierno Journal: Cancer Epidemiol Biomarkers Prev Date: 2012-10 Impact factor: 4.254
Authors: Shilo Lefresne; Eric Berthelet; Rosemary Cashman; Karen Levy; Mitchel Liu; Hannah Carolan; Michael McKenzie; Paula Kostuik; Robert Olson Journal: Support Care Cancer Date: 2014-07-08 Impact factor: 3.603
Authors: Angel Arnaout; Jennifer Smylie; Jean Seely; Susan Robertson; Kathy Knight; Salome Shin; Tim Ramsey; Ranjeeta Mallick; James Watters Journal: Ann Surg Oncol Date: 2013-08-22 Impact factor: 5.344